ArticlePloS one2012

A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.

Raymond Poon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.